Oracle Health Launches Medical Device Validation Program to Boost Connected Care

Oracle’s new program seeks to address these challenges through an EHR-agnostic architecture, simplifying integration for healthcare technology customers.

Oracle Health has launched a new three-tier validation framework for medical devices, aimed at standardizing connectivity, functionality, and workflow alignment to enable secure integration within healthcare organizations.

Validated devices will also have the opportunity to be listed in the Oracle Healthcare Marketplace.

Medical devices often produce inconsistent data, which can disrupt clinical workflows, create operational inefficiencies, and limit the adoption of innovative care models. Oracle’s new program seeks to address these challenges through an EHR-agnostic architecture, simplifying integration for healthcare technology customers. The framework allows evaluation of device connectivity, nomenclature alignment, and workflow integration across different electronic health record systems.

“Oracle Health Device Validation provides the assurance hospitals need to choose our technology,” said Michael Hawn, senior vice president of data services and cloud hosting at Bio IntelliSense.

The program currently supports validation across multiple device categories, including bedside integration, event management, maternal and fetal monitoring, infusion suites, laboratory devices, and mobile vitals collection. It also covers discrete data, continuous and spot-check monitoring, alarms, waveforms, infusion management, smart pump programming, and real-time location services. Oracle noted that ongoing validation supports data transmission security and compliance with interoperability standards.

“Through this validation program, we're building trusted relationships with device vendors, streamlining interoperability, and opening the door for continued collaboration and innovation that gives our customers confidence and improves patient care,” said Seema Verma, general manager of Oracle Health and Life Sciences.

Device vendors have already highlighted the program’s benefits. Peter Richardson, associate director of connected care at Baxter, said, “Our collaboration with Oracle has helped us drive meaningful and agile progress in our technology integration.”

With pandemic-era Acute Hospital Care at Home waivers extended through 2030, the demand for validated, interoperable devices is expected to grow, reinforcing Oracle Health’s role in supporting secure and efficient connected care delivery.

Stay tuned for more such updates on Digital Health News